Camila Guimarães Moreira Zimmer, PhD

Camila Guimarães Moreira Zimmer, PhD began their career in 2015 as a Study Director and Researcher at Centro de Inovação e Ensaios Pré-Clínicos (CIEnP). Camila then moved on to become a Postdoctoral Research Fellow at the same organization. In 2020, they took on the role of Chief Executive Officer at HomeoSkin. Currently, they are the Head of Preclinical Research and Development at Aptah Biosciences.

Camila Guimarães Moreira Zimmer, PhD obtained their Doctor of Philosophy degree in Pharmacology from the Universidade Federal do Paraná in 2014. Camila also holds a Master's degree in Pharmacology from the same university.